Home  > Clinical services  >  Individualized Treatment With High -throughput Sequencing  > Intended group

1. After the tumor is diagnosed: patients who are seeking a more suitable drug program;

2. Tumor drugs have poor efficacy: patients who hope to find better drug programs;

3. Available target drugs are not found after conventional detection: patients who are seeking treatment opportunities for more target drugs;

4. Due to the emergence of drug resistance: patients who require change treatment programs.


All rights reserved Annoroad Gene Technology 京ICP备12029022号-1